Brief: Active Biotech Receives Milestone Payment From Neotx
Dec 11 (Reuters) - Active Biotech AB (publ) ACTI.ST :
* REG-ACTIVE BIOTECH RECEIVE MILESTONE PAYMENT FROM NEOTX
* ACTIVE BIOTECH AB (PUBL) TODAY ANNOUNCE A MILESTONE
PAYMENT OF
USD 750 000 FROM PARTNER NEOTX THERAPEUTICS (NEOTX) UNDER TERMS
OF LICENSE AGREEMENT ON IMMUNOTHERAPY NAPTUMOMAB.
Source text for Eikon: ID:nGNE2B0p07
Further company coverage: ACTI.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Active Biotech AB publ
See all newsBrief: Active Biotech Says Japan Grants Patent For Laquinimod Ophthalmic Formulation
Brief: Active Biotech Reports Q2 Operating Profit Of SEK -10.2 Mln
Brief: Active Biotech Expands U.S. Collaboration
Brief: Active Biotech Gets Approval To Resume Enrolment In Hovon 172 MF Study
Brief: Active Biotech Q1 Loss After Tax At SEK 8.4 Million